This inventor holds 7 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2006-2017.
Location History:
- Reims Cedex 2, FR (2006 - 2007)
- Reims, FR (2009)
- Reims Cedex, FR (2009)
- Cheshire, GB (2015)
- Macclesfield, GB (2011 - 2017)
Company Filing History:
Years Active: 2006-2017
Title: Benedicte Delouvrie: Innovator in Chemical Compounds
Introduction
Benedicte Delouvrie, an accomplished inventor residing in Macclesfield, GB, has made significant contributions to the field of chemical compounds. With a remarkable portfolio of 7 patents, her innovative work primarily focuses on the development of pharmaceutical compositions and processes aimed at treating various cell proliferative disorders.
Latest Patents
Benedicte's latest patents revolve around the invention of chemical compounds which include compounds of Formula (I) or pharmaceutically-acceptable salts thereof. These patents detail innovative processes for their preparation, as well as the pharmaceutical applications and methodologies involved in treating cell proliferative disorders.
Career Highlights
Currently, Benedicte is associated with AstraZeneca AB, a leading global biopharmaceutical company. Her expertise in the field has allowed her to focus on the essential research and development of new therapies, contributing significantly to advancements in medicine.
Collaborations
Throughout her career, Benedicte has collaborated with notable individuals such as Craig Steven Harris and Gilles Ouvry. These partnerships reflect her dedication to working within teams that advance scientific knowledge and drive innovation in the pharmaceutical industry.
Conclusion
Benedicte Delouvrie's contributions to the field of chemical compounds and her active role at AstraZeneca AB underscore her importance as an inventor. Her ongoing work not only enhances our understanding of chemical compounds but also plays a crucial role in developing effective treatments for serious health conditions.